We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biomechanical Ratchet Traps Cancer Cells Before They Can Spread

By LabMedica International staff writers
Posted on 29 Jun 2009
Researchers have demonstrated the possibility of using a biomechanical ratchet to sort normal and cancerous cells as a means to trap tumor cells before they spread to other areas of the body. More...


In several important physiologic processes, particularly cancer metastasis, randomly moving cells can acquire a directional motility phenotype and bias their motions in response to environmental cues. Researchers still do not understand why cells migrate in a specific direction.

In the current study, researchers from Northwestern University (Evanston, IL, USA) incorporated molecular cues (cell-adhesive and cell-repellant chemical compounds) into a "microgeometry” substrate that was keyed to the difference in shape between normal epithelial (long and thin with long protrusions on the ends) and cancer (round and broad) cells.

The microscopic ratchets contained channels with "spikes” protruding at 45o angles from the walls, alternating on opposite sides of the channel. This pattern funneled cancer cells in one direction while at the same time directing the normal cells in the opposite direction, as those cells could attach to the spikes and pull themselves through the channel. The cancer cells could be channeled into a closed chamber from which they could not escape.

The feasibility of the system was tested using melanoma, breast cancer, and normal cells, and the results were reported in the June 14, 2009, online edition of the journal Nature Physics.

"We have demonstrated a principle that offers an unconventional way to fight metastasis, a very different approach from other methods, such as chemotherapy,” said senior author Dr. Bartosz Grzybowski, associate professor of chemical and biological engineering at Northwestern University. "These are fundamental studies so the method needs to be optimized, but the idea has promise for a new approach to cancer therapy.”

Related Links:

Northwestern University



Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Automated Chemiluminescence Immunoassay Analyzer
MS-i3080
Silver Member
PCR Plates
Diamond Shell PCR Plates
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The researchers identified gene expression and signaling pathways linked to severe RSV infection and future wheezing risk in children (Photo courtesy of Shutterstock)

New Biomarkers Predict Disease Severity in Children with RSV Bronchiolitis

Respiratory syncytial virus (RSV) remains a leading cause of acute bronchitis in infants and young children and continues to contribute significantly to global childhood illness and mortality.... Read more

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.